News >

Expert Highlights Latest Advances, Next Steps in HER2+ Breast Cancer

Caroline Seymour
Published: Thursday, May 09, 2019

Joanne Mortimer, MD

Joanne Mortimer, MD

Data from the phase III KATHERINE trial in early HER2-positive breast cancer and smaller studies in the metastatic setting are shaping modern treatment models and testifying to the prospect of improved prognoses, explained Joanne Mortimer, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication
x